Search In this Thesis
   Search In this Thesis  
العنوان
Cardiac Troponin “T” in Neonates with Severe and Moderate Persistent Pulmonary Hypertension/
المؤلف
Yousif,Shaimaa Yakoot Abd Elatif
هيئة الاعداد
باحث / شيماء ياقوت عبد اللطيف يوسف
مشرف / طارق محى-الجماصي
مشرف / امنية إبراهيم يوسف
مشرف / نهى رفعت محمد
الموضوع
Cardiac Troponin “T” in Neonates-
تاريخ النشر
2014
عدد الصفحات
153
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
طب الأطفال ، الفترة المحيطة بالولادة وصحة الطفل
تاريخ الإجازة
1/10/2014
مكان الإجازة
جامعة عين شمس - كلية الطب - Pediatrics
الفهرس
Only 14 pages are availabe for public view

from 154

from 154

Abstract

Persistent pulmonary hypertension of the newborn (PPHN), a major clinical problem in the neonatal intensive care unit, can contribute significantly to morbidity and mortality in both term and preterm infants. (Steinhorn and Farrow, 2007)
PPHN induced circulatory failure further impairs oxygen delivery to the tissues and contributes to significant mortality and morbidity in newborn infants with PPHN. (Tourneux et al, 2008)
A comprehensive echocardiographic examination is an integral element of the initial evaluation of newborns with PPHN, both in order to exclude structural congenital heart disease, and to assess cardiac function. (Fraisse et al, 2004)
Cardiac troponins (cTnT) are highly specific cardiac markers, extremely sensitive and valuable in diagnostics of myocardial damage. (Agzew, 2009)
The aim of current study was to evaluate myocardial injury in moderate and severe persistent pulmonary hypertension of newborn (PPHN) in neonates using Echocardiography and measuring serum cardiac Troponin T (cTnT) levels in those patients.
This cross sectional study was carried out in the neonatal intensive care units (NICU) of Pediatrics department, Ain Shams University hospitals in the period from October 2012 to April 2014.
The study included 2 groups: Group I (gpI) included 30 full term (≥37wks) neonates with PPHN; they were 24 (80%) males and 6 (20%) females with a mean gestational age 37.63wk ± 1.05 days and Group II (gpII) included 30 apparently healthy age and sex matched neonates that served as a control group. They were 24 (80%) males and 6 (20%) females with a mean gestational age 37.867± 0.67 days.
The diagnosis of PPHN was based on the echocardiographic evidence of persistent pulmonary hypertension (right-to-left or bidirectional shunt shunting of blood across the ductus arteriosus and/or the foramen ovale) in newborns (Bassler et al, 2010); clinically postnatal period of cyanosis where the level of hypoxia is disproportionate to the degree of respiratory distress or respiratory distress which often with respiratory failure and the need for high ventilator pressures and increase oxygen requirements. (Evans et al, 1997)
Neonates with structural congenital heart diseases, primary parenchymal lung disease, sepsis and genetic syndrome or inborn error of metabolism were excluded from the study.
All gpI were subdivided into 2 groups: patients with moderate PPHN 56.4% and patients with severe PPHN 43.33% according estimated PAP, direction of shunting, orientation of ventricular septum and systolic function of the left ventricle.
All newborns included in this study were subjected to Full detailed history including: Perinatal history (perinatal asphyxia or hypoxia, maternal drug intake and maternal illness), Antenatal history (maternal chronic illnesses as DM and hypertension, history of maternal drug intake, maternal Parity and gravidity, history of premature rupture of membrane and mode of delivery), Natal history (APGAR 1 & 5min, birth weight, gestational age and meconium staining of amniotic fluid or meconium in the trachea), Postnatal history (NICU admission, duration and management).
Detailed clinical assessment including: Anthropometric measures assessment (weight, length and body surface area), Gestational age assessment (the new Ballard scoring system), Vital signs assessment (respiratory rate, heart rate and mean blood pressure) and Systemic examination (respiratory system, cardiovascular system and neurological examination).
Laboratory investigation: ABG (by the AVL OMNI 6 modulator system analyzer), CBC (by the Sysmex SF-3000 auto-analyzer system), CRP (by latex agglutination using BioMed-CRP latex reagent), and cTnT levels (by electrochemilunescence immunoassay (ECLIA).
Radiological investigation: Chest X-ray (postro-anterior view), M mode, 2D, colored, continuous wave, pulsed Doppler echocardiography (Vivid i; General Electric Medical Systems, Horten, Norway): For assessment of cardiac chamber size, pulmonary pressure, valvular status, cardiac systolic (EF). Right and Left ventricular functions were also assessed by Tissue Doppler imaging (TDI) (Sm, Em, Am, Em\Am), (ST, ET, AT, ET\AT), PEP/ET, Tei index, Strain and Strain rate.
The results of current study showed that, a significant increase was found in history of maternal DM, Hypertension, and presence of MAS in patient group (gpI) than controls (gpII) (P=0.012). Also, a highly significant increase was found in patients (gpI) delivered by CS than controls (gpII) (P= 0.009).
A highly significant decrease was found in Apgar score at 1min and 5min in gpI than gpII. (P=0.0009 and 0.0003).
Moreover, comparison of vital signs in gpI and gpII revealed that a highly significant decrease was found in mean Blood pressure (Bp) values and a highly significant increase was found in mean Heart rate (HR) and mean Respiratory rate (RR) (P=0.0004, 0.000 and 0.000 respectively).
As for cardiac examination, sixty percent 60% of gpI had accentuated S2, 33.3% had audible systolic murmur and 6.67% had sinus tachycardia >170 beats/minute.
Concerning oxygen saturation by pulse oximetery in 1st 72h of life, all gpI was hypoxemic (suspected CCHD ≤95%).
ABGs findings revealed that 70% of gpI had mixed acidosis (respiratory and metabolic) and 30% had respiratory acidosis. Also, 68.7% had normal PaO2, 13.3% had mild hypoxemia (70-79mmHg), 6.7% had moderate hypoxemia (60-69mmHg) and 3.3% had severe hypoxemia (59-50mmHg).
As for ventilation in gpI, 57% mechanically ventilated (SIMV) while 43% were not.
As regards X-ray findings on admission day, seven percent (7%) of patients had MAS (Bilateral patchy infiltrates) and 93% had no evidence of lung pathology.
As for M-mode data in gpI and gpII, a highly significant decrease was found in EF%, mean LVEDD and mean LAD (P=0.0000, 0.0000 and 0.0000); a significant decrease was found in mean IVS thickness (P=0.0099); a highly significant increase was found in PASP and RVDD (P=0.0000 and 0.0000) and a highly significant increase was found in PWT (P=0.065).
All gpI had PFO (56.6% bidirectional and 43.33% right to left shunt) while 10% of gpII had PFO (left to right shunt) and 60% of gpI had PDA.
As for systolic time interval ratios of both ventricles, A highly significant increase in right and left ventricular PEP/ET was found in gpI compared to gpII (P=0.0000 and 0.0000 respectively). This indicates RV and LV systolic dysfunction.
Assessment of ventricular systolic function by Tissue Doppler Imaging (TDI) revealed a highly significant decrease was found in mean values of peak mitral annular systolic motion velocity (Sm) and peak tricuspid annular systolic motion velocity (ST) in gpI compared to gpII (P=0.0000 and 0.0000 respectively).
10% of gpI neonates were found with systolic dysfunction by conventional echocardiography (EF% ˂55%) vs. 43.33% by TDI (Sm˂4.61cm/s) indicating that this technique is a better tool in cardiac dysfunction.
As for ventricular diastolic function, a highly significant decrease was found in left peak mitral annular late diastolic velocity (Am), left peak mitral annular early diastole velocity (Em) and mean values of Em/Am ratio in gpI compared to gpII (P=0.0000, 0.0003 and 0.0000 respectively). As well as right peak tricuspid annular late diastolic velocity (AT), right peak tricuspid annular early diastole velocity (ET) and mean values of ET/AT ratio were found in gpI compared to gpII (P=0.0000, 0.0000 and 0.0000 respectively); denoting ventricular diastolic dysfunction in those patients.
Consequently RV and LV Tissue Doppler derived Tei indices (TDI-Tei) were found to be a highly significant increase in gpI compared to gpII (P=0.0000 and 0.0000 respectively).
A highly significant decrease in Regional systolic right ventricular Strain and Strain Rate was found in gpI than gpII (P=0.000, 0.000, 0.000, 0.000, 0.000 and 0.000 respectively).
As regards serum cTnT levels, a highly significant increase was found in cTnT levels in gpI than gpII (P=0.0000); in patients who needed than those who didn’t need mechanical ventilation (P=0.01) and in Patients who died compared to those who survived (P=0.022).
As regards correlation studies, a highly significant negative correlation was found between cTnT levels and (PH, PO2, HCO3 and BE) and a highly significant positive correlation was found between cTnT levels and PCO2 (P=0.0000).
A significant positive correlation was found between cTnT levels and mean values of RVDD, PDA diameter, EPAP, right and left ventricular PET/ET.
A highly significant negative correlation was found between cTnT levels and left ventricular motion velocity (Sm, Em and Em/Am). Also, a highly significant negative correlation was found between cTnT levels and right ventricular motion velocity (ST, ET and ET/AT).
A highly significant positive correlation was found between cTnT levels and right and left ventricular Tei index.
A highly significant negative correlation was found between cTnT levels and right mid ventricular strain rate.